Enamel matrix derivative enhances tissue formation around scaffolds used for tissue engineering of ligaments

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 2, 2010, Pages 96-104

  Messenger, Michael P ^b   Raïf, El M ^a   Seedhom, Bahaa B ^b   Brookes, Steven J ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS DENTAL INSTITUTE   (United Kingdom)

Author keywords

Amelogenin; Anterior cruciate ligament; Emdogain ; Enamel matrix derivative; Synovial cells; Synoviocytes; Tissue engineering; Xelma

Indexed keywords

BIOSYNTHESIS; CELL ENGINEERING; CELLS; CYTOLOGY; ELECTRON MICROSCOPES; PROTEINS; SCAFFOLDS (BIOLOGY); TISSUE;

AMELOGENIN; ANTERIOR CRUCIATE LIGAMENT; CELL/B.E; EMDOGAIN®; ENAMEL MATRIX DERIVATIVES; IN-VITRO; SYNOVIAL CELLS; SYNOVIOCYTES; TISSUES ENGINEERINGS; XELMA®;

ELECTRON MICROSCOPY;

CALCIUM; COLLAGEN; DNA; EMDOGAIN; ENAMEL MATRIX DERIVATIVE; POLYETHYLENE TEREPHTHALATE; SCLEROPROTEIN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTERIOR CRUCIATE LIGAMENT; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; COW; DNA CONTENT; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; MOLECULAR WEIGHT; NONHUMAN; PERIODONTAL DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SCANNING ELECTRON MICROSCOPY; SYNOVIOCYTE; TISSUE ENGINEERING; TISSUE REPAIR;

EID: 77649208142     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.210     Document Type: Article

References (47)

1. Altman GH, Horan RL, Lu HH, et al. 2002; Silk Matrix for Tissue Engineered Anterior Cruciate Ligaments. Biomaterials 23: 4131-4141.
2. Amiel D, Kleiner JB, Roux RD, et al. 1986; The phenomenon of 'ligamentization': anterior cruciate ligament reconstruction with autogenous patellar tendon. J Orthop Res 4: 162-172.
3. Arnoczky SP, Tarvin GB, Marshall JL. 1982; Anterior cruciate ligament replacement using patellar tendon. An evaluation of graft revascularization in the dog. J Bone Joint Surg Am 64: 217-224.
4. Barber FA. 2003; Should allografts be used for routine anterior cruciate ligament reconstructions? Arthroscopy 19: 421.
5. Clayton ML, Miles JS, Abdulla M. 1968; Experimental investigations of ligamentous healing. Clin Orthop 61: 146.
6. Cooper JA, Jr., et al. 2007; Biomimetic Tissue-Engineered Anterior Cruciate Ligament Replacement. Proc Natl Acad Sci USA 104: 3049-3054.
7. De Bari C, Dell'Accio F, Tylzanowski P, et al. 2001; Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942.
8. Fan H, Liu H, Wong EJ, Toh SL, Goh JC. 2008; In vivo study of anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold. Biomaterials 29(23): 3324-3337.
9. Fu FH, Jackson DW, Jamison J, et al. 1993; Allograft reconstruction of the anterior cruciate ligament. In The Anterior Cruciate Ligament: Current and Future Concepts. Raven: New York; 325-338.
10. Fujikawa, K. 1989; Clinical Study on Anterior Cruciate Ligament Reconstruction with the Scaffold Type Artificial Ligament (Leeds-Keio). Nippon Seikeigeka Gakkai Zasshi 63: 774-788.
11. Fujikawa K, Kobayashi T, Sasazaki Y, et al. 2000; Anterior cruciate ligament reconstruction with the Leeds-Keio artificial ligament. J Long Term EffMed Implants 10: 225-238.
12. Fujikawa K, Seedhom B, Matsumoto H, et al. 1993; The Leeds-Keio Ligament. In Intra-articular Reconstruction of the Anterior Cruciate Ligament. Butterworth-Heinemann: London; 173-207.
13. Gestrelius S, Andersson C, Johansson AC, et al. 1997a; Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontol 24: 678-684.
14. Gestrelius S, Andersson C, Lidstrom D, et al. 1997b; In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 24: 685-692.
15. Grayson RE, Yamakoshi Y, Wood EJ, et al. 2006; The effect of the amelogenin fraction of enamel matrix proteins on fibroblast-mediated collagen matrix reorganization. Biomaterials 27: 2926-2933.
16. Hammarstrom L. 1997; Enamel matrix, cementum development and regeneration. J Clin Periodontol 24: 658-668.
17. Herrington L, Wrapson C, Matthews M, et al. 2005; Anterior cruciate ligament reconstruction, hamstring versus bone-patellar tendon-bone grafts: a systematic literature review of outcome from surgery. Knee 12: 41-50.
18. Hoemann CD, Sun J, Chrzanowski V, et al. 2002; Amultivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 300: 1-10.
19. Jones AP, Sidhom S, Sefton G. 2007; Long-term clinical review (10-20 years) after reconstruction of the anterior cruciate ligament using the Leeds-Keio synthetic ligament. J Long Term Eff Med Implants 17: 59-69.
20. Jones EA, English A, Henshaw K, et al. 2004; Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthrit Rheum 50: 817-827.
21. Kawase T, Okuda K, Momose M, et al. 2001; Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodont Res 36: 367-376.
22. Keila S, Nemcovsky CE, Moses O, et al. 2004; In vitro effects of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J Dent Res 83: 134-138.
23. Lacerda-Pinheiro S, Jegat N, Septier D, et al. 2006; Early in vivo and in vitro effects of amelogenin gene splice products on pulp cells. Eur J Oral Sci 114: 232-238.
24. Laurencin CT, Freeman JW. 2005; Ligament tissue engineering: an evolutionary materials science approach. Biomaterials 26: 7530-7536.
25. Laurencin CT, Freeman JW, Woods MD. 2006; A novel tissue engineered scaffold for anterior cruciate ligament repair: relation of funtional properties to scaffold structure. J Biomech 39: S59.
26. Lettry S, Roccavilla F, Seedhom B. 2000; Abrasion of artificial ligaments: a simulative study. J Orthop Sci 5: 481-488.
27. Lyngstadaas P, Ekdahl H, Lundberg E, et al. 1999; Increased TGF production in PDL cells. J Dent Res 78: 189 (abstr 671).
28. Lyngstadaas SP, Lundberg E, Ekdahl H, et al. 2001; Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 28: 181-188.
29. Messenger MP, Raif EM, Seedhom BB, et al. 2007; The potential use of enamel matrix derivative for in situ anterior cruciate ligament tissue engineering: a translational in vitro investigation. Tissue Eng 13: 2041-2051.
30. Mizutani S, Tsuboi T, Tazoe M, et al. 2003; Involvement of FGF-2 in the action of Emdogain on normal human osteoblastic activity. Oral Dis 9: 210-217.
31. Nebgen DR, Inoue H, Sabsay B, et al. 1999; Identification of the chondrogenic-inducing activity from bovine dentin (bCIA) as a low-molecular-mass amelogenin poypeptide. J Dent Res 78: 1484-1494.
32. Parkar MH, Tonetti M. 2004; Gene expression profiles of periodontal ligament cells treated with enamel matrix proteins in vitro: analysis using cDNA arrays. J Periodontol 75: 1539-1546.
33. Poddevin N, King MW, Guidoin RG. 1997; Failure mechanisms of anterior cruciate ligament prostheses: in vitro wear study. J Biomed Mater Res 38: 370-381.
34. Raif EM. 2008; Effect of cyclic tensile load on the regulation of the expression of matrix metalloproteases (MMPs -1, -3) and structural components in synovial cells. J Cell Mol Med 12: 2439-2448.
35. Raïf EM, Seedhom BB. 2005; Effect of cyclic tensile strain on proliferation of synovial cells seeded onto synthetic ligament scaffolds - an in vitro simulation. Bone 36: 433-443.
36. Sugihara A, Fujikawa K, Watanabe H, et al. 2006; Anterior cruciate reconstruction with bioactive Leeds-Keio ligament (LKII): preliminary report. J Long Term Eff Med Implants 16: 41-49.
37. Tompkins K, Alvares K, George A, et al. 2005; Two related low molecular mass polypeptide isoforms of amelogenin have distinct activities in mouse tooth germ differentiation in vitro. J Bone Miner Res 20: 341-349.
38. Tsukazaki S, Kikuchi T, Fujikawa K, et al. 2003; Comparative study of the covered area of Leeds-Keio (LK) artificial ligament and radio frequency generated glow discharge treated Leeds-Keio (Bio-LK) ligament with synovial cells, J Long Term Eff Med Implants 13: 355-362.
39. van der Pauw MTM, Van den Bos T, Everts V, et al. 2000; Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor β1 release of periodontal ligament and gingival fibroblasts. J Periodontol 71: 31-43.
40. Veis A, Tompkins K, Alvares K, et al. 2000; Sepcific amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo. J Biol Chem 275: 41263-41272.
41. Veis A. 2003; "Amelogenin Gene Splice Products: Potential Signaling Molecules". Cell Mol Life Sci 60: 38-55.
42. Vowden P, Romanelli M, Peter R, et al. 2006; The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers. Wound Repair Regen 14: 240-246.
43. Vowden P, Romanelli M, Price P. 2007; Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers. J Wound Care 16: 189-195.
44. Vunjak-Novakovic G, Altman G, Horan R, et al. 2004; Tissue engineering of ligaments. Annu Rev Biomed Eng 6: 131-156.
45. Westermeier R 1997; Electrophoresis in practice: a guide to methods and applications of DNA and protein separations. Wiley-VCH, Weinheim, Germany.
46. Wieser RJ, Oesch F. 1986; Contact inhibition of growth of human diploid fibroblasts by immobilized plasma membrane glycoproteins. J Cell Biol 103: 361-367.
47. Zeichner-David M, Chen LS, Hsu Z, et al. 2006; Amelogenin and ameloblastin show growth-factor like activity in periodontal ligament cells. Eur J Oral Sci 114: 244-253.